Orgenesis Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 6.03, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2024. Average receivable collection period, for the Orgenesis Inc in Dec 31 2024 quarter, has decreased to 61 days, compared to 121 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 325 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2673, from overall ranking in the third quarter 2024 at 3527.

What is Receivable Turnover Ratio?
What is Orgenesis Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ORGS Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	-92.67 %	126.76 %	-75.31 %	-98.98 %	-98.6 %
Y / Y Revenue Change	82.42 %	215.45 %	117.7 %	-0.7 %	-98.79 %
Receivable Turnover Ratio (TTM)	6.03	3.02	2.4	1.15	0.08
ORGS's Total Ranking	# 2673	# 3527	# 3503	# 3618	# 3131
Accounts Receivable average collection period days	60	121	152	316	4418
Seq. Receivable Change	-75.16 %	-32.92 %	-2.04 %	-55.13 %	669.01 %
Seq. Revenue Change	-13.26 %	41.06 %	74.47 %	-14.55 %	50 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 102
Healthcare Sector	# 326
Overall Market	# 2673

Receivable Turnover Ratio Statistics
High	Average	Low
11.93	3.73	0.08
(Nov 30 2016)		(Dec 31 2023)

ORGS Company Profile • Back to ORGS Efficiency Comparisons • Compare ORGS Receivables Turnover Ratio to its Competitors

Financial Statements
Orgenesis Inc 's Accounts Receivable	$ 0 Millions	Visit ORGS's Balance sheet
Orgenesis Inc 's Sales TTM	$ 1 Millions	Visit ORGS's Income Statement
Sources of ORGS's Revenues		Visit ORGS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ORGS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ORGS's Growth Rates	ORGS's Roa	ORGS's Inventory Turnover Ratio	ORGS's Dividend Comparisons
ORGS's Profitability Ratios	ORGS's Roi	ORGS's Asset Turnover Ratio	ORGS's Dividend Growth
ORGS's Valuation Ratios	ORGS's Roe	ORGS's Financial Strength Ratios	ORGS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Zeo Scientifix Inc	65.32	$ 4.556 Millions	$ 0.070 Millions
Mersana Therapeutics inc	63.03	$ 40.497 Millions	$ 0.643 Millions
Brookdale Senior Living Inc	61.19	$ 3,125.487 Millions	$ 51.080 Millions
Lucid Diagnostics Inc	59.33	$ 4.346 Millions	$ 0.073 Millions
23andme Holding Co	55.62	$ 207.779 Millions	$ 3.736 Millions
Aclaris Therapeutics Inc	55.10	$ 18.720 Millions	$ 0.340 Millions
Nature s Sunshine Products inc	43.36	$ 453.688 Millions	$ 10.464 Millions
Vireo Growth Inc.	42.50	$ 99.384 Millions	$ 2.339 Millions
Aesthetic Medical International Holdings Group Limited	41.71	$ 105.026 Millions	$ 2.518 Millions
Pavmed Inc	40.61	$ 3.249 Millions	$ 0.080 Millions
Pluri Inc	39.88	$ 0.678 Millions	$ 0.017 Millions
Curevac N v	39.74	$ 579.065 Millions	$ 14.571 Millions
Marpai Inc	38.10	$ 27.977 Millions	$ 0.734 Millions
Metagenomi Therapeutics Inc	37.51	$ 52.295 Millions	$ 1.394 Millions
One World Products Inc	33.83	$ 0.005 Millions	$ 0.000 Millions
Monte Rosa Therapeutics Inc	33.61	$ 75.622 Millions	$ 2.250 Millions
Xoma Royalty Corporation	33.39	$ 28.487 Millions	$ 0.853 Millions
Vivos Therapeutics Inc	33.30	$ 15.019 Millions	$ 0.451 Millions
Electrocore Inc	33.28	$ 24.397 Millions	$ 0.733 Millions
Igc Pharma Inc	32.96	$ 1.236 Millions	$ 0.038 Millions
Eyepoint Inc	32.20	$ 43.273 Millions	$ 1.344 Millions
Keros Therapeutics Inc	32.20	$ 27.046 Millions	$ 0.840 Millions
National Vision Holdings Inc	31.43	$ 1,823.320 Millions	$ 58.018 Millions
Aquestive Therapeutics Inc	31.35	$ 57.561 Millions	$ 1.836 Millions
Lifemd Inc	30.80	$ 211.815 Millions	$ 6.877 Millions
Agape Atp Corporation	30.25	$ 1.323 Millions	$ 0.044 Millions
Invo Fertility Inc	30.17	$ 6.532 Millions	$ 0.217 Millions
Orchestra Biomed Holdings Inc	29.81	$ 2.638 Millions	$ 0.089 Millions
U S Physical Therapy Inc	29.80	$ 671.345 Millions	$ 22.531 Millions
Cv Sciences Inc	29.03	$ 15.168 Millions	$ 0.523 Millions

Date modified: 2026-10-07T00:41:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.